<?xml version="1.0" encoding="UTF-8"?>
<svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" viewBox="0 0 1280 768">
  <!-- Generator: Adobe Illustrator 30.0.0, SVG Export Plug-In . SVG Version: 2.1.1 Build 123)  -->
  <defs>
    <style>
      .st0 {
        font-size: 20.03px;
      }

      .st0, .st1, .st2, .st3 {
        font-family: MyriadPro-Bold, 'Myriad Pro';
        font-weight: 700;
      }

      .st0, .st4, .st2 {
        fill: #5ac4be;
      }

      .st5 {
        filter: url(#drop-shadow-8);
      }

      .st6 {
        fill: url(#linear-gradient2);
      }

      .st7 {
        fill: url(#linear-gradient1);
      }

      .st8 {
        fill: url(#linear-gradient3);
      }

      .st9 {
        fill: url(#linear-gradient5);
      }

      .st10 {
        fill: url(#linear-gradient4);
      }

      .st11 {
        fill: #2b388f;
      }

      .st12 {
        fill: url(#radial-gradient);
      }

      .st13 {
        fill: url(#linear-gradient);
      }

      .st14 {
        font-size: 10px;
      }

      .st14, .st3 {
        fill: #231f20;
      }

      .st15 {
        stroke: #fff;
        stroke-width: 3.95px;
      }

      .st15, .st16, .st17, .st18, .st19, .st20 {
        stroke-miterlimit: 10;
      }

      .st15, .st21 {
        fill: #243a78;
      }

      .st16, .st17 {
        fill: none;
        stroke: #231f20;
        stroke-width: .78px;
      }

      .st22 {
        filter: url(#drop-shadow-36);
      }

      .st23 {
        font-family: MyriadPro-Regular, 'Myriad Pro';
      }

      .st17 {
        stroke-dasharray: 4.59 4.59;
      }

      .st24, .st18, .st19, .st25, .st26 {
        fill: #fff;
      }

      .st27 {
        fill: #000b8c;
      }

      .st18, .st19 {
        stroke: #2b388f;
        stroke-width: 2.63px;
      }

      .st18, .st19, .st25, .st26 {
        font-family: BerkshireSwash-Regular, 'Berkshire Swash';
      }

      .st18, .st25 {
        font-size: 34.66px;
      }

      .st28 {
        opacity: .3;
      }

      .st19, .st26 {
        font-size: 27.67px;
      }

      .st20 {
        fill: url(#radial-gradient1);
        stroke: #000b8c;
        stroke-width: 1.6px;
      }

      .st2 {
        font-size: 18.02px;
      }

      .st3 {
        font-size: 15.58px;
      }
    </style>
    <linearGradient id="linear-gradient" x1="-1598.21" y1="-777.12" x2="-1597.49" y2="-777.12" gradientTransform="translate(351197.94 -170515.78) scale(219.5 -219.5)" gradientUnits="userSpaceOnUse">
      <stop offset="0" stop-color="#6f58a4"/>
      <stop offset="1" stop-color="#2b388f"/>
    </linearGradient>
    <radialGradient id="radial-gradient" cx="640.48" cy="384" fx="640.48" fy="384" r="527.76" gradientUnits="userSpaceOnUse">
      <stop offset="0" stop-color="#fff"/>
      <stop offset="1" stop-color="#edffff"/>
    </radialGradient>
    <filter id="drop-shadow-8" x="35.44" y="676.63" width="153.04" height="81.56" filterUnits="userSpaceOnUse">
      <feOffset dx="3.73" dy="3.73"/>
      <feGaussianBlur result="blur" stdDeviation="3.73"/>
      <feFlood flood-color="#231f20" flood-opacity=".4"/>
      <feComposite in2="blur" operator="in"/>
      <feComposite in="SourceGraphic"/>
    </filter>
    <linearGradient id="linear-gradient1" x1="1747.77" y1="132.42" x2="584.22" y2="127.75" gradientUnits="userSpaceOnUse">
      <stop offset="0" stop-color="#fff" stop-opacity="0"/>
      <stop offset=".68" stop-color="#2b388f"/>
    </linearGradient>
    <linearGradient id="linear-gradient2" x1="304.38" y1="674.33" x2="304.38" y2="552.4" gradientUnits="userSpaceOnUse">
      <stop offset="0" stop-color="#fff" stop-opacity="0"/>
      <stop offset="1" stop-color="#b1e3e1"/>
    </linearGradient>
    <linearGradient id="linear-gradient3" x1="512.71" x2="512.71" xlink:href="#linear-gradient2"/>
    <linearGradient id="linear-gradient4" x1="721.05" x2="721.05" xlink:href="#linear-gradient2"/>
    <linearGradient id="linear-gradient5" x1="929.39" x2="929.39" xlink:href="#linear-gradient2"/>
    <filter id="drop-shadow-36" x="1214.08" y="704.75" width="40.65" height="40.65" filterUnits="userSpaceOnUse">
      <feOffset dx="5.59" dy="5.59"/>
      <feGaussianBlur result="blur1" stdDeviation="3.99"/>
      <feFlood flood-color="#000" flood-opacity=".75"/>
      <feComposite in2="blur1" operator="in"/>
      <feComposite in="SourceGraphic"/>
    </filter>
    <radialGradient id="radial-gradient1" cx="1234.41" cy="725.08" fx="1234.41" fy="725.08" r="19.53" gradientUnits="userSpaceOnUse">
      <stop offset="0" stop-color="#fff"/>
      <stop offset="1" stop-color="#f1f1f1"/>
    </radialGradient>
  </defs>
  <polygon class="st13" points="555.91 56.74 556.98 56.74 556.98 57.81 556.98 57.81 556.98 56.74 555.91 56.74 555.91 56.74"/>
  <g>
    <rect class="st12" x=".48" width="1280" height="768"/>
    <g class="st5">
      <text class="st18" transform="translate(68.67 711.56) rotate(-.27)"><tspan x="0" y="0">Eternal </tspan></text>
      <g>
        <g>
          <path class="st15" d="M65.45,714.95c-.11.14-.15.32-.11.5l2.71,12.04c.06.27.3.46.58.46h.57c.9-2.06,1.4-4.34,1.39-6.73-.01-2.31-.5-4.51-1.36-6.51l-3.32.02c-.18,0-.35.08-.46.22Z"/>
          <path class="st15" d="M40.02,728.11l2.6-12.07c.04-.17,0-.36-.12-.5-.11-.14-.28-.22-.46-.22l-3.52.02c-.72,1.87-1.11,3.9-1.1,6.03.01,2.58.61,5.03,1.68,7.2h.35c.28,0,.52-.2.57-.47Z"/>
          <path class="st15" d="M66.19,724.41l-2.02-8.85c-.12-.54-.61-.92-1.16-.92-.02,0-.05,0-.07,0l-7.09.47c-.27.02-.52.13-.72.31l-.29.26-.31-.28c-.22-.2-.5-.3-.79-.3h-2.94s-5.96.04-5.96.04c-.55,0-1.03.39-1.15.93l-2.05,9.38c-.08.38.02.77.28,1.05.23.25.54.38.87.38.05,0,.1,0,.15-.01l2.8-.37,7.52,5.81.78.72c.23.21.52.31.81.31.08,0,.15,0,.23-.02.26-.02.51-.13.71-.32l5.35-5.04,2.64-2.44.93.27c.11.03.22.05.33.05.3,0,.58-.11.81-.32.3-.29.43-.71.34-1.12ZM61.56,725.96s-.04-.04-.06-.06l-5.08-4.65c-.24-.22-.61-.2-.83.04-.22.24-.2.61.04.83l5.08,4.64-.37.35-.83.78s0,0,0-.01c-.03-.04-.06-.08-.1-.11l-4.22-3.72c-.24-.22-.62-.19-.83.05-.22.24-.19.62.05.83l4.22,3.72s.02.01.02.02c0,0,.01,0,.02.01l-1.22,1.15s-.01-.02-.02-.04c-.03-.05-.07-.1-.12-.15l-3.46-3.05c-.24-.22-.62-.19-.83.05-.22.24-.19.62.05.83l3.46,3.05s.04.03.05.04c.02.01.03.02.05.03l-.56.52s-.02-.04-.03-.06c-.04-.08-.09-.16-.17-.22l-.84-.67c-.25-.2-.63-.16-.83.09l-.6.75-.03.04-.5-.39.07-.08.59-.74c.2-.26.16-.63-.09-.83l-.84-.67c-.26-.2-.63-.16-.83.09l-.48.61-.19.24-.5-.39.22-.28.6-.76c.2-.26.16-.63-.09-.83l-.84-.67c-.25-.2-.63-.16-.83.09l-.5.63-.35.44-.31-.24-.19-.15s.01,0,.02-.01c.05-.03.09-.07.13-.11l.26-.33.62-.78c.2-.26.16-.63-.09-.83l-.84-.67c-.26-.2-.63-.16-.83.09l-.51.65-.37.46s0,0,0,0c-.05.06-.08.13-.1.2l-.71-.55-.33.04-2.96.39,2.05-9.38,5.96-.03h2.94s.23.19.23.19l.1.09-1.84,2.31-.75.95s-.35.39-.32.84c.01.16.07.32.22.48.68.74,2.23.16,2.23.16l1.92-2.31s.25-.33.69-.5l6.79,6.1-1.44,1.36Z"/>
        </g>
        <path class="st15" d="M55.25,755.22l1.79-19.93c.03-.29-.06-.58-.24-.79-.18-.21-.43-.32-.68-.3l-3.96.49c-.72,3.13-.96,6.48-.62,9.93.41,4.19.68,8.08,2.49,11.47l.48-.05c.39-.04.69-.38.73-.83Z"/>
      </g>
      <text class="st19" transform="translate(66.47 747.4) rotate(-.27)"><tspan x="0" y="0">rust</tspan></text>
      <text class="st25" transform="translate(68.67 711.56) rotate(-.27)"><tspan x="0" y="0">Eternal </tspan></text>
      <g>
        <g>
          <path class="st21" d="M65.45,714.95c-.11.14-.15.32-.11.5l2.71,12.04c.06.27.3.46.58.46h.57c.9-2.06,1.4-4.34,1.39-6.73-.01-2.31-.5-4.51-1.36-6.51l-3.32.02c-.18,0-.35.08-.46.22Z"/>
          <path class="st21" d="M40.02,728.11l2.6-12.07c.04-.17,0-.36-.12-.5-.11-.14-.28-.22-.46-.22l-3.52.02c-.72,1.87-1.11,3.9-1.1,6.03.01,2.58.61,5.03,1.68,7.2h.35c.28,0,.52-.2.57-.47Z"/>
          <path class="st21" d="M66.19,724.41l-2.02-8.85c-.12-.54-.61-.92-1.16-.92-.02,0-.05,0-.07,0l-7.09.47c-.27.02-.52.13-.72.31l-.29.26-.31-.28c-.22-.2-.5-.3-.79-.3h-2.94s-5.96.04-5.96.04c-.55,0-1.03.39-1.15.93l-2.05,9.38c-.08.38.02.77.28,1.05.23.25.54.38.87.38.05,0,.1,0,.15-.01l2.8-.37,7.52,5.81.78.72c.23.21.52.31.81.31.08,0,.15,0,.23-.02.26-.02.51-.13.71-.32l5.35-5.04,2.64-2.44.93.27c.11.03.22.05.33.05.3,0,.58-.11.81-.32.3-.29.43-.71.34-1.12ZM61.56,725.96s-.04-.04-.06-.06l-5.08-4.65c-.24-.22-.61-.2-.83.04-.22.24-.2.61.04.83l5.08,4.64-.37.35-.83.78s0,0,0-.01c-.03-.04-.06-.08-.1-.11l-4.22-3.72c-.24-.22-.62-.19-.83.05-.22.24-.19.62.05.83l4.22,3.72s.02.01.02.02c0,0,.01,0,.02.01l-1.22,1.15s-.01-.02-.02-.04c-.03-.05-.07-.1-.12-.15l-3.46-3.05c-.24-.22-.62-.19-.83.05-.22.24-.19.62.05.83l3.46,3.05s.04.03.05.04c.02.01.03.02.05.03l-.56.52s-.02-.04-.03-.06c-.04-.08-.09-.16-.17-.22l-.84-.67c-.25-.2-.63-.16-.83.09l-.6.75-.03.04-.5-.39.07-.08.59-.74c.2-.26.16-.63-.09-.83l-.84-.67c-.26-.2-.63-.16-.83.09l-.48.61-.19.24-.5-.39.22-.28.6-.76c.2-.26.16-.63-.09-.83l-.84-.67c-.25-.2-.63-.16-.83.09l-.5.63-.35.44-.31-.24-.19-.15s.01,0,.02-.01c.05-.03.09-.07.13-.11l.26-.33.62-.78c.2-.26.16-.63-.09-.83l-.84-.67c-.26-.2-.63-.16-.83.09l-.51.65-.37.46s0,0,0,0c-.05.06-.08.13-.1.2l-.71-.55-.33.04-2.96.39,2.05-9.38,5.96-.03h2.94s.23.19.23.19l.1.09-1.84,2.31-.75.95s-.35.39-.32.84c.01.16.07.32.22.48.68.74,2.23.16,2.23.16l1.92-2.31s.25-.33.69-.5l6.79,6.1-1.44,1.36Z"/>
        </g>
        <path class="st21" d="M55.25,755.22l1.79-19.93c.03-.29-.06-.58-.24-.79-.18-.21-.43-.32-.68-.3l-3.96.49c-.72,3.13-.96,6.48-.62,9.93.41,4.19.68,8.08,2.49,11.47l.48-.05c.39-.04.69-.38.73-.83Z"/>
      </g>
      <text class="st26" transform="translate(66.47 747.4) rotate(-.27)"><tspan x="0" y="0">rust</tspan></text>
    </g>
    <g>
      <path class="st11" d="M1279.86,723.58H250.83c-1.93,0-1.93,3,0,3h1029.03c1.93,0,1.93-3,0-3h0Z"/>
      <circle class="st11" cx="239.07" cy="725.53" r="4.9"/>
      <circle class="st11" cx="225.12" cy="725.53" r="4.9"/>
      <circle class="st11" cx="211.16" cy="725.53" r="4.9"/>
    </g>
    <g>
      <path class="st11" d="M.48,55.81h1036.47c1.93,0,1.93-3,0-3H.48c-1.93,0-1.93,3,0,3H.48Z"/>
      <circle class="st11" cx="1048.7" cy="53.86" r="4.9"/>
      <circle class="st11" cx="1062.65" cy="53.86" r="4.9"/>
      <circle class="st11" cx="1076.61" cy="53.86" r="4.9"/>
    </g>
    <g>
      <path class="st21" d="M1154.86,56.45c-.16-4.27-.32-9.38-.32-14.6h-.11c-1.16,4.53-2.64,9.6-4.01,13.76l-4.32,13.87h-6.27l-3.79-13.71c-1.16-4.22-2.32-9.23-3.22-13.92h-.1c-.16,4.8-.37,10.28-.58,14.71l-.69,13.5h-7.44l2.27-35.53h10.7l3.48,11.92c1.16,4.06,2.21,8.49,3,12.65h.21c.95-4.11,2.16-8.75,3.37-12.76l3.74-11.81h10.54l1.9,35.53h-7.8l-.58-13.6Z"/>
      <path class="st21" d="M1171.31,40.9c-2.69,0-4.43-1.9-4.43-4.27s1.79-4.27,4.53-4.27,4.43,1.85,4.48,4.27c0,2.37-1.74,4.27-4.53,4.27h-.05ZM1167.36,44.27h8.01v25.78h-8.01v-25.78Z"/>
      <path class="st21" d="M1185.86,44.27l2.53,4.32c.74,1.32,1.42,2.58,2.11,3.85h.11c.69-1.42,1.32-2.69,2-4.01l2.27-4.16h8.7l-8.49,12.28,8.59,13.5h-9.07l-2.58-4.64c-.74-1.27-1.42-2.58-2-3.9h-.16c-.63,1.37-1.32,2.64-1.95,3.9l-2.42,4.64h-8.81l8.75-13.13-8.54-12.65h8.96Z"/>
      <path class="st21" d="M1208.96,40.9c-2.69,0-4.43-1.9-4.43-4.27s1.79-4.27,4.53-4.27,4.43,1.85,4.48,4.27c0,2.37-1.74,4.27-4.53,4.27h-.05ZM1205,44.27h8.01v25.78h-8.01v-25.78Z"/>
      <path class="st21" d="M1218.34,70.05v-19.87h-3.43v-5.9h3.43v-1c0-3.11.95-6.54,3.22-8.65,2.05-1.9,4.8-2.58,7.17-2.58,1.74,0,3.11.26,4.22.53l-.32,6.17c-.69-.21-1.53-.37-2.58-.37-2.64,0-3.74,2.06-3.74,4.59v1.32h5.17v5.9h-5.11v19.87h-8.01Z"/>
      <path class="st21" d="M1187.48,80.91c-.37.19-1.13.38-2.1.38-2.25,0-3.93-1.42-3.93-4.04s1.69-4.19,4.16-4.19c.98,0,1.62.21,1.89.35l-.26.84c-.38-.19-.94-.33-1.6-.33-1.87,0-3.11,1.2-3.11,3.29,0,1.96,1.12,3.21,3.05,3.21.64,0,1.28-.13,1.69-.33l.2.83Z"/>
      <path class="st21" d="M1189.79,78.47c.02,1.41.91,1.99,1.95,1.99.75,0,1.21-.13,1.59-.29l.19.73c-.37.16-1,.37-1.92.37-1.75,0-2.81-1.17-2.81-2.88s1.03-3.1,2.7-3.1c1.87,0,2.35,1.64,2.35,2.7,0,.21,0,.38-.03.5h-4.01ZM1192.83,77.73c0-.65-.27-1.69-1.43-1.69-1.06,0-1.51.97-1.6,1.69h3.03Z"/>
      <path class="st21" d="M1195.81,81.16v-4.93h-.79v-.79h.79v-.27c0-.8.19-1.54.68-2,.39-.38.91-.53,1.38-.53.38,0,.69.08.89.16l-.13.81c-.17-.07-.37-.13-.67-.13-.88,0-1.11.78-1.11,1.66v.31h1.38v.79h-1.37v4.93h-1.04Z"/>
      <path class="st21" d="M1200.25,74.38c-.39,0-.65-.31-.65-.67s.27-.66.67-.66.66.3.66.66-.26.67-.67.67h-.01ZM1199.76,75.43h1.04v5.72h-1.04v-5.72Z"/>
      <path class="st21" d="M1203.59,75.43l.82,1.22c.21.33.39.62.58.94h.03c.19-.33.38-.63.58-.94l.79-1.22h1.14l-1.95,2.77,2,2.96h-1.18l-.84-1.29c-.22-.33-.41-.65-.61-.99h-.02c-.19.34-.39.65-.6.99l-.83,1.29h-1.15l2.03-2.92-1.94-2.8h1.16Z"/>
      <path class="st21" d="M1209.67,74.38c-.39,0-.65-.31-.65-.67s.27-.66.68-.66.66.3.66.66-.26.67-.68.67h-.01ZM1209.17,75.43h1.04v5.72h-1.04v-5.72Z"/>
      <path class="st21" d="M1212.52,76.98c0-.6-.02-1.07-.05-1.55h.91l.05.92h.03c.32-.54.85-1.05,1.81-1.05.77,0,1.36.47,1.61,1.15h.02c.18-.33.41-.57.65-.74.34-.26.71-.4,1.25-.4.77,0,1.89.5,1.89,2.48v3.37h-1.02v-3.24c0-1.11-.42-1.76-1.24-1.76-.6,0-1.05.44-1.24.93-.05.15-.08.35-.08.52v3.55h-1.02v-3.43c0-.92-.4-1.57-1.2-1.57-.64,0-1.12.52-1.29,1.04-.06.15-.08.33-.08.51v3.45h-1.02v-4.18Z"/>
      <path class="st21" d="M1223.56,78.47c.02,1.41.91,1.99,1.95,1.99.74,0,1.21-.13,1.58-.29l.19.73c-.37.16-1,.37-1.92.37-1.75,0-2.81-1.17-2.81-2.88s1.03-3.1,2.7-3.1c1.87,0,2.36,1.64,2.36,2.7,0,.21-.01.38-.04.5h-4.01ZM1226.6,77.73c0-.65-.27-1.69-1.43-1.69-1.06,0-1.51.97-1.6,1.69h3.03Z"/>
      <path class="st21" d="M1241.82,32.72c2.32,0,4.17,1.89,4.17,4.21s-1.85,4.23-4.19,4.23-4.21-1.87-4.21-4.23,1.89-4.21,4.21-4.21h.02ZM1241.78,33.56c-1.76,0-3.18,1.52-3.18,3.39s1.42,3.37,3.2,3.37c1.78.02,3.22-1.48,3.22-3.37s-1.44-3.39-3.22-3.39h-.02ZM1241.07,39.38h-.99v-4.68c.37-.06.79-.13,1.5-.13.8,0,1.29.13,1.61.37.26.21.41.52.41,1.01,0,.56-.39.95-.9,1.09v.04c.41.07.67.45.75,1.14.09.73.19,1.01.26,1.16h-1.03c-.11-.17-.19-.58-.28-1.22-.07-.51-.37-.71-.88-.71h-.45v1.93ZM1241.07,36.69h.47c.58,0,1.03-.19,1.03-.67,0-.39-.28-.69-.95-.69-.24,0-.41,0-.54.02v1.35Z"/>
    </g>
  </g>
  <rect class="st7" x="1.44" y="97.49" width="1280.38" height="60.99"/>
  <text class="st14" transform="translate(72.57 179.11)"><tspan class="st1" x="0" y="0">INDICATIONS:</tspan><tspan class="st23" x="62.47" y="0"> </tspan><tspan class="st1" x="64.25" y="0">Mixif® </tspan><tspan class="st23" x="93.07" y="0">is active against most strains of the following Gram-positive and Gram-negative organisms: Streptococcus pneumonia, Streptococcus pyogenes, Streptococcus agalactiae, Haemophilus influenza, Haemophilus parainfluenza, Moraxella (Branhamella) catarrhalis, </tspan><tspan class="st23" x="0" y="12">Escherichia coli, Proteus mirabilis, Proteus vulgaris, Neisseria gonorrhoeae, Klebsiella pneumoniae, Klebsiella oxytoca, Pasteurella multocida, Providencia species, Salmonella species, Shigella species, Citrobacter diversus, Serratia marcescens. </tspan><tspan class="st1" x="988.9" y="12">Mixif® </tspan><tspan class="st23" x="1017.81" y="12">is indicated in the treatment of the </tspan><tspan class="st23" x="0" y="24">following:• Pharyngitis, tonsillitis and sinusitis.• Acute bronchitis and acute exacerbations of chronic bronchitis.• Otitis media.• Uncomplicated urinary tract infections.• Uncomplicated urethral or cervical gonorrhea.• Bacterial gastroenteritis. </tspan><tspan class="st1" x="1036.65" y="24">Contraindications:</tspan><tspan class="st23" x="1119.05" y="24"> </tspan><tspan class="st1" x="1123.1" y="24">Mixif® </tspan><tspan class="st23" x="1154.08" y="24">is </tspan><tspan class="st23" x="0" y="36">contraindicated in patients with known allergy to cephalosporin group of antibiotics </tspan><tspan class="st1" x="353.22" y="36">SIDE</tspan><tspan class="st23" x="373.77" y="36"> </tspan><tspan class="st1" x="375.94" y="36">EFFECTS:</tspan><tspan class="st23" x="416.59" y="36" xml:space="preserve"> Most of adverse reactions observed are of a mild and transient nature. The most common are gastrointestinal events, which are very common in adult patients on either the BID or </tspan><tspan class="st23"><tspan x="0" y="48">the QD regimen. Most of the gastrointestinal events are clinically mild. Gastrointestinal adverse events included diarrhea (very common), loose or frequent stools, abdominal pain, nausea, dyspepsia, and flatulence which were common. The incidence of gastrointestinal adverse </tspan></tspan><tspan class="st23"><tspan x="0" y="60">reactions, including diarrhea and loose stools, in pediatric patients receiving the suspension was comparable to the incidence seen in adult patients. These symptoms usually respond to symptomatic therapy or ceased when cefixime was discontinued. Severe diarrhea and/or </tspan></tspan><tspan class="st23"><tspan x="0" y="72">documented pseudomembranous colitis may occur, a few patients required hospitalization. The following adverse reactions have been reported following the use of cefixime. Incidence rates were less than 2%, except for gastrointestinal events. Gastrointestinal: Diarrhea, loose stools, </tspan></tspan><tspan class="st23"><tspan x="0" y="84">abdominal pain, dyspepsia, nausea, and vomiting. Several cases of documented pseudomembranous colitis were identified during the studies. The onset of pseudomembranous colitis symptoms may occur during or after therapy. Hypersensitivity Reactions: </tspan></tspan><tspan class="st23"><tspan x="0" y="96">Anaphylactic/anaphylactoid reactions (including shock and fatalities), skin rashes, urticaria, drug fever, pruritus, angioedema, and facial edema. Erythema multiforme, Stevens-Johnson syndrome, and serum sickness-like reactions have been reported. Hepatic: Transient elevations in </tspan></tspan><tspan class="st23"><tspan x="0" y="108">SGPT, SGOT, alkaline phosphatase, hepatitis, jaundice. Renal: Transient elevations in BUN or creatinine, acute renal failure. Central Nervous System: Headaches, dizziness, seizures. Hemic and Lymphatic Systems: Transient thrombi cytopenia, leukopenia, neutropenia, and eosinophilia. </tspan></tspan><tspan class="st23"><tspan x="0" y="120">Prolongation in prothrombin time was seen rarely. Abnormal Laboratory Tests: Hyperbilirubinemia. Other: Genital pruritus, vaginitis, candidiasis, toxic epidermal necrolysis. In addition to the adverse reactions listed above which have been observed in patients treated with cefixime, </tspan></tspan><tspan class="st23"><tspan x="0" y="132">the following adverse reactions and altered laboratory tests have been reported for cephalosporin-class antibiotics: Adverse reactions: Allergic reactions, superinfection, renal dysfunction, toxic nephropathy, hepatic dysfunction including cholestasis, aplastic anemia, hemolytic </tspan></tspan><tspan class="st23"><tspan x="0" y="144">anemia, hemorrhage, and colitis. Several cephalosporins have been implicated in triggering seizures, particularly in patients with renal impairment when the dosage was not reduced. If seizures associated with drug therapy occur, the drug should be discontinued. Anticonvulsant </tspan></tspan><tspan class="st23" x="0" y="156">therapy can be given if clinically indicated. Abnormal Laboratory Tests: Positive direct Coombs test, elevated LDH, pancytopenia, agranulocytosis. </tspan><tspan class="st1" x="606.07" y="156">WARNINGS AND PRECAUTIONS:</tspan><tspan class="st23" x="747.75" y="156" xml:space="preserve"> WARNINGS Before therapy with cefixime is instituted, careful inquiry should be made to determine </tspan><tspan class="st23"><tspan x="0" y="168">whether the patient has had previous hypersensitivity reactions to cephalosporins, penicillins, or other drugs. If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibiotics has been clearly </tspan></tspan><tspan class="st23"><tspan x="0" y="180">documented and may occur in up to 10% of patients with a history of penicillin allergy. If an allergic reaction to cefixime occurs, discontinue the drug. Serious acute hypersensitivity reactions may require treatment with epinephrine and other emergency measures, including oxygen, </tspan></tspan><tspan class="st23"><tspan x="0" y="192">intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated. Anaphylactic/anaphylactoid reactions (including shock and fatalities) have been reported with the use of cefixime. Antibiotics, including cefixime, should </tspan></tspan><tspan class="st23"><tspan x="0" y="204">be administered cautiously to any patient who has demonstrated some form of allergy, particularly to drugs. Treatment with broad spectrum antibiotics, including cefixime, alters the normal flora of the colon and may permit overgrowth of clostridia. A toxin produced by Clostridium </tspan></tspan><tspan class="st23"><tspan x="0" y="216">difficile is a primary cause of severe antibiotic-associated diarrhea including pseudomembranous colitis. Pseudomembranous colitis has been reported with the use of cefixime and other broad-spectrum macrolides, antibiotics (including semisynthetic penicillins, and </tspan></tspan><tspan class="st23"><tspan x="0" y="228">cephalosporins);therefore, it is important to consider this diagnosis in patients who develop diarrhea in association with the use of antibiotics. Symptoms of pseudomembranous colitis may occur during or after antibiotic treatment and may range in severity from mild to </tspan></tspan><tspan class="st23"><tspan x="0" y="240">life-threatening. Mild cases of pseudomembranous colitis usually respond to drug discontinuation alone. In moderate to severe cases, management should include fluids, electrolytes, and protein supplementation. If the colitis does not improve after the drug has been discontinued, </tspan></tspan><tspan class="st23" x="0" y="252">or if the symptoms are severe, oral vancomycin is the drug of choice for antibiotic-associated pseudomembranous colitis produced by C. difficile. Other causes of colitis should be excluded. </tspan><tspan class="st1" x="781.63" y="252">PRECAUTIONS:</tspan><tspan class="st23" x="848.44" y="252" xml:space="preserve"> The possibility of the emergence of resistant organisms which might result </tspan><tspan class="st23"><tspan x="0" y="264">in overgrowth should be kept in mind, particularly during prolonged treatment. In such use, careful observation of the patient is essential. If superinfection occurs during therapy, appropriate measures should be taken. The dose of cefixime should be adjusted in patients with renal </tspan></tspan><tspan class="st23"><tspan x="0" y="276">impairment as well as those undergoing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD). Patients on dialysis should be monitored carefully. Cefixime should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. </tspan></tspan><tspan class="st23"><tspan x="0" y="288">Cephalosporins may be associated with a fall in prothrombin activity. Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant </tspan></tspan><tspan class="st23" x="0" y="300">therapy. Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated. </tspan><tspan class="st1" x="492.77" y="300">Mixif® </tspan><tspan class="st23" x="521.77" y="300">Suspension contains approximately 2.3 grams sucrose per dose:• This should be taken into account in patients with diabetes mellitus. If you have been told </tspan><tspan class="st23" x="0" y="312">by your doctor that you have intolerance to some sugars, inform your doctor before taking this medicinal product.. Sucrose may be harmful to teeth. </tspan><tspan class="st1" x="614.44" y="312">DOSAGE AND ADMINISTRATION:</tspan><tspan class="st23" x="759.84" y="312" xml:space="preserve"> Adults: The recommended dose of </tspan><tspan class="st1" x="906.54" y="312">Mixif® </tspan><tspan class="st23" x="935.56" y="312">is 400 mg daily. This may be given as a 400 mg capsule </tspan><tspan class="st23"><tspan x="0" y="324">once daily, or as a 200 mg capsule every 12 hours. For the treatment of uncomplicated urethral or cervical gonococcal infections, a single oral dose of 400 mg is recommended. Children: The recommended dose is 8 mg/kg/day of suspension. This may be administered as a single daily </tspan></tspan><tspan class="st23"><tspan x="0" y="336">dose or may be given in two divided doses, as 4 mg/kg every 12 hours. Children weight more than 50 kg or older than 12 years should be treated with the recommended adult dose.</tspan></tspan></text>
  <g>
    <g class="st28">
      <rect class="st6" x="202.77" y="552.4" width="203.21" height="121.93"/>
    </g>
    <path class="st4" d="M404.66,659.24c-.8,8.15-7.69,14.53-16.04,14.53h-168.48c-8.35,0-15.24-6.39-16.04-14.53h-1.24c.81,8.81,8.27,15.77,17.29,15.77h168.48c9.01,0,16.48-6.96,17.29-15.77h-1.24Z"/>
    <g>
      <path class="st24" d="M388.62,539.38h-168.48c-8.21,0-14.88,6.68-14.88,14.88s6.68,14.88,14.88,14.88h168.48c8.21,0,14.88-6.68,14.88-14.88s-6.68-14.88-14.88-14.88Z"/>
      <path class="st4" d="M388.62,536.9h-168.48c-9.55,0-17.36,7.81-17.36,17.36s7.81,17.36,17.36,17.36h168.48c9.55,0,17.36-7.81,17.36-17.36s-7.81-17.36-17.36-17.36ZM388.62,569.14h-168.48c-8.21,0-14.88-6.68-14.88-14.88s6.68-14.88,14.88-14.88h168.48c8.21,0,14.88,6.68,14.88,14.88s-6.68,14.88-14.88,14.88Z"/>
    </g>
    <text class="st0" transform="translate(250.12 560.33)"><tspan x="0" y="0">Weight (kg)</tspan></text>
    <text class="st3" transform="translate(289.44 590.07)"><tspan x="0" y="0">6.25</tspan><tspan x="0" y="24.89">12.5</tspan><tspan x="-4.32" y="49.79">18.75</tspan><tspan x="6.35" y="74.68">25</tspan></text>
    <g>
      <line class="st16" x1="202.94" y1="598.52" x2="205.28" y2="598.52"/>
      <line class="st17" x1="209.87" y1="598.52" x2="400.55" y2="598.52"/>
      <line class="st16" x1="402.85" y1="598.52" x2="405.19" y2="598.52"/>
    </g>
    <g>
      <line class="st16" x1="202.94" y1="622.52" x2="205.28" y2="622.52"/>
      <line class="st17" x1="209.87" y1="622.52" x2="400.55" y2="622.52"/>
      <line class="st16" x1="402.85" y1="622.52" x2="405.19" y2="622.52"/>
    </g>
    <g>
      <line class="st16" x1="202.94" y1="648.34" x2="205.28" y2="648.34"/>
      <line class="st17" x1="209.87" y1="648.34" x2="400.55" y2="648.34"/>
      <line class="st16" x1="402.85" y1="648.34" x2="405.19" y2="648.34"/>
    </g>
    <g class="st28">
      <rect class="st8" x="411.11" y="552.4" width="203.21" height="121.93"/>
    </g>
    <path class="st4" d="M613,659.24c-.8,8.15-7.69,14.53-16.04,14.53h-168.48c-8.35,0-15.24-6.39-16.04-14.53h-1.24c.81,8.81,8.27,15.77,17.29,15.77h168.48c9.01,0,16.48-6.96,17.29-15.77h-1.24Z"/>
    <g>
      <path class="st24" d="M596.96,539.38h-168.48c-8.21,0-14.88,6.68-14.88,14.88s6.68,14.88,14.88,14.88h168.48c8.21,0,14.88-6.68,14.88-14.88s-6.68-14.88-14.88-14.88Z"/>
      <path class="st4" d="M596.96,536.9h-168.48c-9.55,0-17.36,7.81-17.36,17.36s7.81,17.36,17.36,17.36h168.48c9.55,0,17.36-7.81,17.36-17.36s-7.81-17.36-17.36-17.36ZM596.96,569.14h-168.48c-8.21,0-14.88-6.68-14.88-14.88s6.68-14.88,14.88-14.88h168.48c8.21,0,14.88,6.68,14.88,14.88s-6.68,14.88-14.88,14.88Z"/>
    </g>
    <text class="st0" transform="translate(445.41 560.33)"><tspan x="0" y="0">Dose/day (mg)</tspan></text>
    <text class="st3" transform="translate(504.13 590.07)"><tspan x="0" y="0">50</tspan><tspan x="-4.32" y="24.89">100</tspan><tspan x="-4.32" y="49.79">150</tspan><tspan x="-4.32" y="74.68">200</tspan></text>
    <g>
      <line class="st16" x1="411.28" y1="598.52" x2="413.61" y2="598.52"/>
      <line class="st17" x1="418.21" y1="598.52" x2="608.89" y2="598.52"/>
      <line class="st16" x1="611.19" y1="598.52" x2="613.53" y2="598.52"/>
    </g>
    <g>
      <line class="st16" x1="411.28" y1="622.52" x2="413.61" y2="622.52"/>
      <line class="st17" x1="418.21" y1="622.52" x2="608.89" y2="622.52"/>
      <line class="st16" x1="611.19" y1="622.52" x2="613.53" y2="622.52"/>
    </g>
    <g>
      <line class="st16" x1="411.28" y1="648.34" x2="413.61" y2="648.34"/>
      <line class="st17" x1="418.21" y1="648.34" x2="608.89" y2="648.34"/>
      <line class="st16" x1="611.19" y1="648.34" x2="613.53" y2="648.34"/>
    </g>
    <g class="st28">
      <rect class="st10" x="619.45" y="552.4" width="203.21" height="121.93"/>
    </g>
    <path class="st4" d="M821.34,659.24c-.8,8.15-7.69,14.53-16.04,14.53h-168.48c-8.35,0-15.24-6.39-16.04-14.53h-1.24c.81,8.81,8.27,15.77,17.29,15.77h168.48c9.01,0,16.48-6.96,17.29-15.77h-1.24Z"/>
    <g>
      <path class="st24" d="M805.29,539.38h-168.48c-8.21,0-14.88,6.68-14.88,14.88s6.68,14.88,14.88,14.88h168.48c8.21,0,14.88-6.68,14.88-14.88s-6.68-14.88-14.88-14.88Z"/>
      <path class="st4" d="M805.29,536.9h-168.48c-9.55,0-17.36,7.81-17.36,17.36s7.81,17.36,17.36,17.36h168.48c9.55,0,17.36-7.81,17.36-17.36s-7.81-17.36-17.36-17.36ZM805.29,569.14h-168.48c-8.21,0-14.88-6.68-14.88-14.88s6.68-14.88,14.88-14.88h168.48c8.21,0,14.88,6.68,14.88,14.88s-6.68,14.88-14.88,14.88Z"/>
    </g>
    <text class="st0" transform="translate(656.85 560.33)"><tspan x="0" y="0">Dose/day (ml)</tspan></text>
    <text class="st3" transform="translate(710.44 590.07)"><tspan x="0" y="0">2.5</tspan><tspan x="0" y="24.89">5.0</tspan><tspan x="0" y="49.79">7.5</tspan><tspan x="-4.32" y="74.68">10.0</tspan></text>
    <g>
      <line class="st16" x1="619.61" y1="598.52" x2="621.95" y2="598.52"/>
      <line class="st17" x1="626.54" y1="598.52" x2="817.23" y2="598.52"/>
      <line class="st16" x1="819.52" y1="598.52" x2="821.86" y2="598.52"/>
    </g>
    <g>
      <line class="st16" x1="619.61" y1="622.52" x2="621.95" y2="622.52"/>
      <line class="st17" x1="626.54" y1="622.52" x2="817.23" y2="622.52"/>
      <line class="st16" x1="819.52" y1="622.52" x2="821.86" y2="622.52"/>
    </g>
    <g>
      <line class="st16" x1="619.61" y1="648.34" x2="621.95" y2="648.34"/>
      <line class="st17" x1="626.54" y1="648.34" x2="817.23" y2="648.34"/>
      <line class="st16" x1="819.52" y1="648.34" x2="821.86" y2="648.34"/>
    </g>
    <g class="st28">
      <rect class="st9" x="827.78" y="552.4" width="203.21" height="121.93"/>
    </g>
    <path class="st4" d="M1029.67,659.24c-.8,8.15-7.69,14.53-16.04,14.53h-168.48c-8.35,0-15.24-6.39-16.04-14.53h-1.24c.81,8.81,8.27,15.77,17.29,15.77h168.48c9.01,0,16.48-6.96,17.29-15.77h-1.24Z"/>
    <g>
      <path class="st24" d="M1013.63,539.38h-168.48c-8.21,0-14.88,6.68-14.88,14.88s6.68,14.88,14.88,14.88h168.48c8.21,0,14.88-6.68,14.88-14.88s-6.68-14.88-14.88-14.88Z"/>
      <path class="st4" d="M1013.63,536.9h-168.48c-9.55,0-17.36,7.81-17.36,17.36s7.81,17.36,17.36,17.36h168.48c9.55,0,17.36-7.81,17.36-17.36s-7.81-17.36-17.36-17.36ZM1013.63,569.14h-168.48c-8.21,0-14.88-6.68-14.88-14.88s6.68-14.88,14.88-14.88h168.48c8.21,0,14.88,6.68,14.88,14.88s-6.68,14.88-14.88,14.88Z"/>
    </g>
    <text class="st2" transform="translate(835.03 560.33)"><tspan x="0" y="0">Dose/day (teaspoonful)</tspan></text>
    <text class="st3" transform="translate(918.78 590.07)"><tspan x="0" y="0">0.5</tspan><tspan x="0" y="24.89">1.0</tspan><tspan x="0" y="49.79">1.5</tspan><tspan x="0" y="74.68">2.0</tspan></text>
    <g>
      <line class="st16" x1="827.95" y1="598.52" x2="830.29" y2="598.52"/>
      <line class="st17" x1="834.88" y1="598.52" x2="1025.56" y2="598.52"/>
      <line class="st16" x1="1027.86" y1="598.52" x2="1030.2" y2="598.52"/>
    </g>
    <g>
      <line class="st16" x1="827.95" y1="622.52" x2="830.29" y2="622.52"/>
      <line class="st17" x1="834.88" y1="622.52" x2="1025.56" y2="622.52"/>
      <line class="st16" x1="1027.86" y1="622.52" x2="1030.2" y2="622.52"/>
    </g>
    <g>
      <line class="st16" x1="827.95" y1="648.34" x2="830.29" y2="648.34"/>
      <line class="st17" x1="834.88" y1="648.34" x2="1025.56" y2="648.34"/>
      <line class="st16" x1="1027.86" y1="648.34" x2="1030.2" y2="648.34"/>
    </g>
  </g>
  <g class="st22">
    <rect class="st20" x="1214.88" y="705.55" width="39.06" height="39.06" rx="8.38" ry="8.38"/>
    <path class="st27" d="M1248.89,722.61l-4.97-4.97v-6.89c0-.24-.19-.43-.43-.43h-3.07c-.24,0-.43.19-.43.43v2.96l-4.53-4.53c-.58-.57-1.51-.57-2.08,0l-13.45,13.44c-.87.87-.35,2.36.87,2.5l2.17.25v14.55c0,.81.66,1.47,1.47,1.47h6.34v-10.56c0-.71.57-1.28,1.28-1.28h4.7c.71,0,1.28.57,1.28,1.28v10.56h6.34c.81,0,1.47-.66,1.47-1.47v-14.56l2.17-.26c1.22-.14,1.74-1.64.87-2.5Z"/>
  </g>
</svg>